Form 8-K

8-K — Privia Health Group, Inc.

Accession: 0001759655-26-000027

Filed: 2026-05-07

Period: 2026-05-07

CIK: 0001759655

SIC: 8000 (SERVICES-HEALTH SERVICES)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — prva-20260507.htm (Primary)

EX-99.1 (ex-9911q26earningrelease.htm)

GRAPHIC (privialogo.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: prva-20260507.htm · Sequence: 1

prva-20260507

0001759655FALSE00017596552026-05-072026-05-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________

FORM 8-K

_______________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 7, 2026

_________________________

Privia Health Group, Inc.

(Exact Name of Registrant as Specified in Its Charter)

_________________________

Delaware

001-40365 81-3599420

(State or other jurisdiction of incorporation or organization)

(Commission

File No.)

(I.R.S. Employer Identification No.)

950 N. Glebe Rd.,

Suite 700

Arlington, Virginia 22203

(Address of Principal Executive Offices)

(Zip Code)

(571) 366-8850

Registrant's telephone number, including area code

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered

Common Stock, $0.01 par value per share PRVA The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On May 7, 2026, Privia Health Group, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2026. A copy of the press release is attached hereto as Exhibit 99.1.

The information in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, are “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibit:

Exhibit No. Description

99.1

Privia Health Group, Inc. Press Release Dated May 7, 2026

104

The Cover Page from this Current Report on Form 8-K, Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PRIVIA HEALTH GROUP, INC.

Date: May 7, 2026

By: /s/ David Mountcastle

Name: David Mountcastle

Title: Executive Vice President, Chief Financial Officer and Authorized Officer

EX-99.1

Filename: ex-9911q26earningrelease.htm · Sequence: 2

Document

Exhibit 99.1

Privia Health Reports First Quarter 2026 Financial Results

–Strong First Quarter Performance and Operating Execution

–Reiterated Full-Year 2026 Guidance Reflects Continued Momentum

ARLINGTON, VA – May 7, 2026 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2026.

Three Months Ended March 31,

(unaudited; $ in millions, except per share amounts)

2026 2025

Change (%)*

Total revenue $ 603.8 $ 480.1 25.8 %

Gross profit $ 125.6 $ 103.6 21.2 %

Operating income $ 7.4 $ 5.2 42.2 %

Net income a

$ 3.1 $ 4.2 (27.4) %

Non-GAAP adjusted net income b

$ 24.3 $ 19.9 22.3 %

Net income per share $ 0.02 $ 0.03 (33.3) %

Non-GAAP adjusted net income per share b

$ 0.19 $ 0.16 18.8 %

*Any slight variations in totals are due to rounding.

a.Net income for the three months ended March 31, 2026, included $21.9 million in non-cash stock compensation expense. Net income for the three months ended March 31, 2025 included $17.8 million in non-cash stock compensation expense.

b.Reconciliations of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release.

First Quarter 2026 highlights include:

•Continued strength in same-store growth and new provider additions;

•Practice Collections of $914.8M, +14.6% versus 1Q’25; and

•Adjusted EBITDA c e f of $36.7M, +36.3% versus 1Q’25.

Key Operating and Non-GAAP Financial Metrics c

Three Months Ended March 31,

(unaudited; $ in millions)

2026 2025 Change (%)

Implemented Providers 5,535 4,871 13.6 %

Value-Based Care Attributed Lives 1,606,000 1,270,000 26.5 %

Practice Collections $ 914.8 $ 798.6 14.6 %

Care Margin

$ 128.7 $ 105.3 22.3 %

Platform Contribution

$ 67.0 $ 51.7 29.6 %

Adjusted EBITDA

$ 36.7 $ 26.9 36.3 %

c.Reconciliations of Care Margin, Platform Contribution, Adjusted EBITDA and other non-GAAP financial measures are presented in tables near the end of this press release.

Updated Full-Year 2026 Guidance d e f g

Privia Health maintained its full-year 2026 outlook for most metrics, and raised its guidance range for Attributed Lives, as follows:

FY 2025

Initial FY 2026 Guidance at 2.27.26 d

Updated FY 2026 Guidance at 5.7.26

($ in millions) Actual Low High

Implemented Providers 5,380 5,900 6,000 Unchanged

Attributed Lives 1,541,000 1,550,000 1,600,000 1,600,000 - 1,625,000

Practice Collections $ 3,470.5 $ 3,650 $ 3,750 Unchanged

GAAP Revenue $ 2,122.8 $ 2,350 $ 2,450 Unchanged

Care Margin d e f

$ 462.2 $ 515 $ 530 Unchanged

Platform Contribution d e

$ 234.8 $ 260 $ 270 Unchanged

Adjusted EBITDA d e f

$ 125.5 $ 145 $ 155 Unchanged

•Expect approximately 80% of Adjusted EBITDA to convert to free cash flow in full-year 2026

•Guidance does not assume any new business development activity

d.Management has not reconciled forward-looking non-GAAP measures to their most directly comparable GAAP measures of Gross Profit, Operating Income and Net Income. This is because the Company cannot predict with reasonable certainty and without unreasonable efforts the ultimate outcome of certain GAAP components of such reconciliations due to market-related assumptions that are not within our control as well as certain legal or advisory costs, tax costs or other costs that may arise. For these reasons, management is unable to assess the probable significance of the unavailable information, which could materially impact the amount of the future directly comparable GAAP measures.

e.See “Key Metrics and Non-GAAP Financial Measures” for more information as to how the Company defines and calculates Implemented Providers, Attributed Lives, Practice Collections, Care Margin, Platform Contribution, and Adjusted EBITDA, and for a reconciliation of the most comparable GAAP measures to Care Margin, Platform Contribution, Adjusted EBITDA, Adjusted Net Income and Adjusted Net Income Per Share.

f.Certain non-recurring or non-cash and other expenses will be treated as an add back in the reconciliation of Net Income to Adjusted EBITDA, and the reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per Share, the details of which can be found in the Reconciliation schedules near the end of this and in future quarterly press releases.

g.Any slight variations in totals due to rounding.

Webcast and Conference Call Information

The Company will host a conference call on May 7, 2026, at 8:00 am ET to discuss these results and management’s outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations to listen to the call via live webcast. The webcast will be archived and available for replay for on-demand listening shortly after the completion of the call under the same link. If you wish to participate in the live conference call, then please dial 888-596-4144 (or 646-968-2525 for international callers) and provide Conference ID 5704885.

This news release and the financial statements contained herein, and the slide presentation for the webcast, are also available on the Privia Health Investor Relations website at ir.priviahealth.com.

About Privia Health

Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 24 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 5.9+ million patients, and reward 5,500+ physicians and advanced practitioners for delivering high-value care.

Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com.

Non-GAAP Financial Measures

The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in the United States ("GAAP"). From time to time, in press releases, financial presentations, earnings conference calls or otherwise, the Company may disclose certain non-GAAP financial measures. The non-GAAP financial measures presented in this press release should not be viewed as alternatives or substitutes for the Company's reported GAAP results. A reconciliation to the most directly comparable GAAP financial measure is set forth in the tables that accompany this release.

The Company believes that the non-GAAP financial measures presented in this press release are relevant and provide useful information to the Company's management, investors, and other interested parties about the Company's operating performance because the measures allow them to understand and compare the Company's actual and expected operating results during the prior, current and future periods in a more consistent manner. The non-GAAP measures presented in this press release may not be comparable to similarly titled measures used by other companies. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provides a more complete understanding of the results of operations and trends affecting the Company's business. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to financial measures calculated in accordance with GAAP.

Safe Harbor Statement

The financial results in this press release reflect preliminary, unaudited results, which are not final until the Company’s Form 10-Q is filed with the Securities and Exchange Commission (“SEC”). This press release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such statements relate to our current expectations, projections and assumptions about our business, the economy and future events or conditions. They do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as “aims,” “anticipates,” "assumes," “believes,” “estimates,” “expects,” “forecasts,” “future,” “intends,” “likely,” “may,” “outlook,” “plans,” “potential,” “projects,” “seeks,” “strategy,” “targets,” “trends,” “will,” “would,” “could,” “should,” and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. In particular, these include statements relating to, among other things, our future actions, business plans, objectives and prospects; and our future operating or financial performance and projections, including our full year guidance for 2026. Factors or events that could cause actual results to differ may emerge from time to time and are difficult to predict. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may

differ materially from past results and those anticipated, estimated or projected. We caution you not to place undue reliance upon any of these forward-looking statements.

Factors related to these risks and uncertainties include, but are not limited to: the heavily regulated industry in which we operate, and any failure by us or our medical groups to comply with the extensive applicable healthcare laws and government regulations; the complexity of the legal framework governing our relationships with Medical Groups, some of which we do not own, and Privia providers, and the impact of legal challenges or shifting interpretations of applicable laws; the execution of our growth strategy, which may not prove viable and we may not realize expected results; difficulties timely implementing our proprietary end-to-end, cloud-based technology solution for Privia physicians and new medical groups; the high level of competition in our industry; challenges in successfully establishing a presence in new geographic markets; the impact of failures by or service disruptions at key third-party vendors, such as our primary electronic medical record vendor, athenahealth, Inc.; potential decreases in reimbursement rates by governmental and third-party payers, changes to payment terms or challenges negotiating and retaining favorable contracts with private third-party payers, and changes impacting our patient population; the financial and operational impact of our compliance with various complex and changing federal and state privacy and security laws and regulations related to our use, disclosure, and other processing of personal information and protected health information, including the Health Insurance Portability and Accountability Act of 1996; the impact of actual and potential security threats, cybersecurity incidents or privacy or other forms of data breaches involving us, our vendors or other third parties; the continued availability of qualified workforce, including staff at our medical groups, and the continued upward pressure on compensation for such workforce; and other risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2025 and the Company’s subsequent Quarterly Reports on Form 10-Q. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.

Contact:

Robert Borchert

SVP, Investor & Corporate Communications

IR@priviahealth.com

817.783.4841

Privia Health Group, Inc.

Condensed Consolidated Statements of Operations(g)

(unaudited)

(in thousands, except share and per share data)

For the Three Months Ended March 31,

2026 2025

Revenue $ 603,847 $ 480,097

Operating expenses:

Provider expense 475,117 374,809

Cost of platform 68,420 59,526

Sales and marketing 8,134 6,922

General and administrative 41,473 31,721

Depreciation and amortization 3,281 1,901

Total operating expenses 596,425 474,879

Operating income

7,422 5,218

Interest income, net

1,888 2,931

Income before provision for income taxes

9,310 8,149

Provision for income taxes 5,600 2,103

Net income 3,710 6,046

Less: Net income attributable to non-controlling interests 646 1,826

Net income attributable to Privia Health Group, Inc. $ 3,064 $ 4,220

Net income per share attributable to Privia Health Group, Inc. stockholders – basic $ 0.02 $ 0.03

Net income per share attributable to Privia Health Group, Inc. stockholders – diluted $ 0.02 $ 0.03

Weighted average common shares outstanding – basic 124,152,526 120,623,670

Weighted average common shares outstanding – diluted 130,878,939 127,752,527

(g) Any slight variations in totals due to rounding.

Privia Health Group, Inc.

Condensed Consolidated Balance Sheets(h)

(in thousands)

March 31, 2026 December 31, 2025

Assets (unaudited)

Current assets:

Cash and cash equivalents $ 419,524 $ 479,685

Accounts receivable

513,676 400,902

Prepaid expenses and other current assets 32,822 30,414

Total current assets 966,022 911,001

Non-current assets:

Property and equipment, net 384 504

Right-of-use assets

8,307 8,794

Intangible assets, net 212,784 215,919

Goodwill 209,842 209,842

Deferred tax asset

— 2,274

Other non-current assets 20,553 21,044

Total non-current assets 451,870 458,377

Total assets $ 1,417,892 $ 1,369,378

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable and accrued expenses $ 80,555 $ 96,804

Provider liability 518,629 469,516

Operating lease liabilities, current 2,114 2,200

Total current liabilities 601,298 568,520

Non-current liabilities:

Operating lease liabilities, non-current 6,907 7,331

Deferred tax liability 254 —

Other non-current liabilities 3,529 2,584

Total non-current liabilities 10,690 9,915

Total liabilities 611,988 578,435

Commitments and contingencies

Stockholders’ equity:

Common stock 1,257 1,236

Additional paid-in capital 905,048 892,291

Accumulated deficit (153,246) (156,310)

Total Privia Health Group, Inc. stockholders’ equity 753,059 737,217

Non-controlling interest 52,845 53,726

Total stockholders’ equity 805,904 790,943

Total liabilities and stockholders’ equity $ 1,417,892 $ 1,369,378

(h) Any slight variations in totals are due to rounding.

Privia Health Group, Inc.

Condensed Consolidated Statements of Cash Flows(i)

(unaudited)

(in thousands)

For the Three Months Ended March 31,

2026 2025

Cash flows from operating activities

Net income

$ 3,710 $ 6,046

Adjustments to reconcile net income to net cash used in operating activities:

Depreciation 146 228

Amortization of intangibles 3,135 1,673

Stock-based compensation 21,921 17,790

Deferred income taxes, net

2,528 1,713

Changes in asset and liabilities:

Accounts receivable, net

(112,774) (72,548)

Prepaid expenses and other current assets (2,408) (914)

Other non-current assets and right-of-use assets

978 275

Accounts payable and accrued expenses (16,249) (13,850)

Provider liability 49,113 35,681

Operating lease liabilities (510) (155)

Other long-term liabilities 945 —

Net cash used in operating activities

(49,465) (24,061)

Cash from investing activities

Other

(26) —

Net cash used in investing activities (26) —

Cash flows from financing activities

Proceeds from exercised stock options

774 2,243

Repurchase of non-controlling interest (11,444) —

Net cash (used in) provided by financing activities

(10,670) 2,243

Net decrease in cash and cash equivalents (60,161) (21,818)

Cash and cash equivalents at beginning of period 479,685 491,149

Cash and cash equivalents at end of period $ 419,524 $ 469,331

Supplemental disclosure of cash flow information:

Interest paid $ 62 $ —

Income tax paid (refunds received) $ 63 $ (313)

(i) Any slight variations in totals are due to rounding.

Additional Financial Information

Revenues disaggregated by source:

For the Three Months Ended March 31,

(Dollars in thousands)

2026 2025

FFS-patient care $ 391,133 $ 311,761

FFS-administrative services 31,403 32,255

Capitated revenue 86,148 70,690

Shared savings 74,962 47,912

Care management fees (PMPM) 17,865 15,201

Other revenue 2,336 2,278

Total Revenue $ 603,847 $ 480,097

The Company’s liabilities for unpaid medical claims under at-risk capitation arrangements:

March 31,

(Dollars in thousands)

2026 2025

Balance, beginning of period $ 78,989 $ 66,355

Incurred health care costs:

Current year 81,143 70,565

Prior years 435 (954)

Total claims incurred $ 81,578 $ 69,611

Claims paid:

Current year (2,088) (10,273)

Prior year (53,239) (39,332)

Total claims paid $ (55,327) $ (49,605)

Balance, end of period $ 105,240 $ 86,361

Key Metrics and Non-GAAP Financial Measures

Privia Health reviews a number of operating and financial metrics, including the following key metrics and non-GAAP financial measures, to evaluate the Company’s business, measure performance, identify trends affecting the Company’s business, formulate business plans, and make strategic decisions.

Key Metrics(j)

For the Three Months Ended March 31,

(unaudited; $ in millions) 2026 2025

Implemented Providers (as of end of period) (1)

5,535 4,871

Attributed Lives (as of end of period) (2)

1,606,000 1,270,000

Practice Collections (3)

$ 914.8 $ 798.6

(1) Implemented Providers is defined as the total of all service professionals at the end of a given period who are credentialed and bill for medical services in both Owned and Non-Owned Medical Groups during that period.

(2) Attributed Lives are defined as any patient that a payer deems attributed to Privia to deliver care as part of a value-based care arrangement through a provider of primary care or specialty services as of the end of a particular period.

(3) Practice Collections are defined as the total collections from all practices in all markets and all sources of reimbursement that the Company receives for delivering care and providing Privia Health’s platform and associated services. Practice Collections differ from revenue by including collections from Non-Owned Medical Groups.

(j) Any slight variations in totals are due to rounding.

Non-GAAP Financial Measures (4)(k)

For the Three Months Ended March 31,

(unaudited; $ in thousands) 2026 2025

Care Margin $ 128,730 $ 105,288

Platform Contribution $ 67,033 $ 51,733

Platform Contribution Margin 52.1% 49.1%

Adjusted EBITDA $ 36,691 $ 26,915

Adjusted EBITDA Margin 28.5% 25.6%

(4) In addition to results reported in accordance with GAAP, Privia Health discloses Care Margin, Platform Contribution, Platform Contribution margin, Adjusted EBITDA and Adjusted EBITDA Margin, which are non-GAAP financial measures. Each are defined as follows:

•Care Margin is Gross Profit excluding amortization of intangible assets.

•Platform Contribution is Gross Profit, excluding amortization of intangible assets, less Cost of platform and excluding stock-based compensation expense included in Cost of platform.

•Platform Contribution margin is Platform Contribution divided by Care Margin.

•Adjusted EBITDA is net income before interest income, net, provision for income taxes, net income attributable to non-controlling interests, depreciation and amortization, stock-based compensation, employer taxes on equity vesting/exercises, severance charges, contingent and deferred consideration, and other non-recurring expenses.

•Adjusted EBITDA Margin is Adjusted EBITDA divided by Care Margin.

(k) Any slight variations in totals are due to rounding.

Reconciliation of Gross Profit to Care Margin(l)

For the Three Months Ended March 31,

(unaudited; $ in thousands) 2026 2025

Revenue $ 603,847 $ 480,097

Provider expense (475,117) (374,809)

Amortization of intangible assets (3,135) (1,673)

Gross Profit $ 125,595 $ 103,615

Amortization of intangibles assets 3,135 1,673

Care Margin $ 128,730 $ 105,288

(l) Any slight variations in totals are due to rounding.

Reconciliation of Gross Profit to Platform Contribution(m)

For the Three Months Ended March 31,

(unaudited; $ in thousands) 2026 2025

Revenue $ 603,847 $ 480,097

Provider expense (475,117) (374,809)

Amortization of intangibles assets (3,135) (1,673)

Gross Profit $ 125,595 $ 103,615

Amortization of intangibles assets 3,135 1,673

Cost of platform (68,420) (59,526)

Stock-based compensation(5)

6,723 5,971

Platform Contribution $ 67,033 $ 51,733

(m) Any slight variations in totals are due to rounding.

(5) Amount represents stock-based compensation expense included in Cost of platform.

Reconciliation of Net Income to Adjusted EBITDA(n)

For the Three Months Ended March 31,

(unaudited; $ in thousands) 2026 2025

Net income

$ 3,064 $ 4,220

Net income attributable to non-controlling interests

646 1,826

Provision for income taxes 5,600 2,103

Interest income, net

(1,888) (2,931)

Depreciation and amortization 3,281 1,901

Stock-based compensation 21,921 17,790

Other expenses(6)

4,067 2,006

Adjusted EBITDA $ 36,691 $ 26,915

(n) Any slight variations in totals are due to rounding.

(6) Other expenses include employer taxes on equity vesting/exercises, severance, contingent and deferred consideration, and other non-recurring expenses.

Reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per Share(o)

For the Three Months Ended March 31,

(unaudited; $ in thousands) 2026

3/31/2025 (9)

Net income $ 3,064 $ 4,220

Stock-based compensation 21,921 17,790

Intangible amortization expense 3,135 1,673

Other expenses(7)

4,067 2,006

Tax effect of adjustments(8)

(7,863) (5,796)

Adjusted net income

$ 24,324 $ 19,893

Adjusted net income per share attributable to Privia Health Group, Inc. stockholders – basic $ 0.20 $ 0.16

Adjusted net income per share attributable to Privia Health Group, Inc. stockholders – diluted $ 0.19 $ 0.16

Weighted average common shares outstanding – basic 124,152,526 120,623,670

Weighted average common shares outstanding – diluted 130,878,939 127,752,527

(o) Any slight variations in totals due to rounding.

(7) Other expenses include employer taxes on equity vesting/exercises, severance, contingent and deferred consideration, and other non-recurring expenses.

(8) The Company uses a statutory blended tax rate of 27% on the adjustments between Net Income and Adjusted Net Income.

(9) Updated to conform with current year presentation.

GRAPHIC

Filename: privialogo.jpg · Sequence: 6

Binary file (8259 bytes)

Download privialogo.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.1

Cover

May 07, 2026

Cover [Abstract]

Document Type

8-K

Document Period End Date

May 07, 2026

Entity Registrant Name

Privia Health Group, Inc.

Entity Incorporation, State or Country Code

Entity File Number

001-40365

Entity Tax Identification Number

81-3599420

Entity Address, Address Line One

950 N. Glebe Rd.,

Entity Address, Address Line Two

Suite 700

Entity Address, State or Province

Entity Address, City or Town

Arlington,

Entity Address, Postal Zip Code

22203

City Area Code

571

Local Phone Number

366-8850

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, $0.01 par value per share

Trading Symbol

PRVA

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

Entity Central Index Key

0001759655

Amendment Flag

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration